Trovagene (TROV) Misses Q1 EPS by 7c

Trovagene (NASDAQ: TROV) reported Q1 EPS of ($0.36), $0.07 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $120 thousand versus the consensus estimate of $260 thousand.

For earnings history and earnings-related data on Trovagene (TROV) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Jack Henry (JKHY) Tops Q4 EPS by 13c
• OMNIQ Corp. posts Q2 2026 revenue of $7.4M, widens net loss